Next-Generation Bioactive Matrix for Personalized Wound Healing

A self-healing hydrogel matrix that embeds a coacervate of polycationic and polyanionic polymers with multiple therapeutic proteins, releasing them in a controlled manner over a prolonged period, and incorporating sensors and machine learning algorithms for personalized wound healing treatment.

The original patent's limitations in terms of protein half-life, dosage, and treatment efficacy are addressed by the new inventive concept, which provides a more ambitious and forward-thinking approach to wound healing by integrating advanced materials, sensors, and AI-driven personalization.

The bioactive matrix comprises a self-healing hydrogel matrix embedded with a coacervate of a polycationic polymer, a polyanionic polymer, and a plurality of therapeutic proteins. The matrix is adapted to release the therapeutic proteins in a controlled manner over a prolonged period of time. The system incorporates a sensor for monitoring the release of the therapeutic proteins, providing real-time feedback to the user. Machine learning algorithms are used to analyze a patient's wound healing profile and generate a customized bioactive matrix tailored to the patient's specific needs.

The new claims introduce the concept of self-healing hydrogel matrices, advanced sensor technology, and AI-driven personalization, which are not present in the original patent. The integration of these elements provides a paradigm shift in wound healing treatment, enabling more effective and targeted therapies.

Alternative embodiments could include the use of different types of polymers, varying the composition of the therapeutic proteins, or incorporating additional sensors or monitoring systems. Variations could include the use of the bioactive matrix for treating other types of injuries or diseases, or integrating the technology with other medical devices or systems.

The next-generation bioactive matrix has significant commercial potential in the wound care and regenerative medicine markets, with potential applications in hospitals, clinics, and home healthcare settings. The technology could also be licensed to medical device companies or used to develop new products and services.